Stereotactic ablative radiotherapy for operable stage I non-small cell lung cancer: not ready for prime time
- PMID: 31656813
- PMCID: PMC6789327
- DOI: 10.21037/atm.2019.08.40
Stereotactic ablative radiotherapy for operable stage I non-small cell lung cancer: not ready for prime time
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.JAMA Oncol. 2019 May 1;5(5):681-688. doi: 10.1001/jamaoncol.2018.6993. JAMA Oncol. 2019. PMID: 30789648 Free PMC article. Clinical Trial.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources